{"database": "openregs", "table": "federal_register", "rows": [["2014-30109", "Bioequivalence Recommendations for Methylphenidate Hydrochloride Extended-Release Oral Suspension; Draft Guidance for Industry; Availability", "Notice", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled \"Bioequivalence Recommendations for Methylphenidate Hydrochloride Extended-Release Oral Suspension.\" The recommendations provide specific guidance on the design of bioequivalence (BE) studies to support abbreviated new drug applications (ANDAs) for methylphenidate hydrochloride (HCl) extended- release oral suspension.", "2014-12-24", 2014, 12, "https://www.federalregister.gov/documents/2014/12/24/2014-30109/bioequivalence-recommendations-for-methylphenidate-hydrochloride-extended-release-oral-suspension", "https://www.govinfo.gov/content/pkg/FR-2014-12-24/pdf/2014-30109.pdf", "Health and Human Services Department; Food and Drug Administration", "221,199", "The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled \"Bioequivalence Recommendations for Methylphenidate Hydrochloride Extended-Release Oral Suspension.\" The recommendations provide specific...", null]], "columns": ["document_number", "title", "type", "abstract", "publication_date", "pub_year", "pub_month", "html_url", "pdf_url", "agency_names", "agency_ids", "excerpts", "regulation_id_numbers"], "primary_keys": ["document_number"], "primary_key_values": ["2014-30109"], "units": {}, "query_ms": 1.2738709338009357, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}